tirzepatide vs semaglutide comparison efficacy side effects Comparative of 2.4 mg vs. 15 mg in Obesity-Related Comorbidity Reduction The bar chart above illustrates a direct between Semaglutide 2.4 mg and… Why You Might Tolerate One

In rodent studies, both semaglutide and tirzepatide caused thyroid tumors

Kosiborod MN, Petrie MC, Borlaug BA et al (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes

Lyzenga-Dean highlights several drawbacks: "These drugs are expensive and rarely covered by insurance for folks who don't meet strict criteria, usually advanced diabetes." Additionally, these medications often require lifelong use to maintain results and can cause serious digestive side effects

Across diabetes and obesity, there are ~20 novel GLP-1 agonists and multi-agonists in Phase 2/3 development (see image 2) , with a host more in earlier stages

Our purpose: Transaction is not the end, but the satarting of service

Tirzepatide is intended for long-term chronic weight management rather than a short-term fix